| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 09/02/2009 | CN101522629A 2-aminocarbonyl-pyridine derivatives |
| 09/02/2009 | CN101522628A Improved electrochemical reduction of halogenated 4-aminopicolinic acids |
| 09/02/2009 | CN101522627A Cyclopropyl compounds and compositions for delivering active agents |
| 09/02/2009 | CN101522626A 3-pyridinecarboxamide and 2-pyrazinecarboxamide derivatives as HDL-cholesterol raising agents |
| 09/02/2009 | CN101522625A Chemical compounds |
| 09/02/2009 | CN101522624A Styrylpyridine derivatives and their use for binding and imaging amyloid plaques |
| 09/02/2009 | CN101522623A Non-flushing niacin analogues, and methods of use thereof |
| 09/02/2009 | CN101519683A Method for resolving and purifying chiral aromatic alcohol compound and partial intermediate products and final products thereof |
| 09/02/2009 | CN101519374A Method for synthesizing derivatives of chiral pyridyl aminoalcohols, and intermediate products and final products of same |
| 09/02/2009 | CN101519373A Method for synthesizing 2,6-difluoropyridine |
| 09/02/2009 | CN101519368A Small molecule entry inhibitors |
| 09/02/2009 | CN101519356A Spiro bisimine and preparation method and application thereof |
| 09/01/2009 | US7582765 Aryl aniline β2 adrenergic receptor agonists |
| 09/01/2009 | US7582668 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 09/01/2009 | US7582661 Antagonists of the chemokine receptor 9 (CCR9); inhibit TECK ligand; antiinflammatory agents and immunoregulators; inflammatory bowel disease; 2-Amino-5-chloro-phenyl)-(3-methyl-pyridin-4-yl)-methanone |
| 09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
| 09/01/2009 | US7582639 Thiocolchicine dimers linked through linear aliphatic amido or amido-ureido bridge; antiproliferative, antiinflammatory, antiarthritic, antiviral agents; cytotoxicity; piperazinedicarboxylic acid bis-(N-deacetylthiocolchicine) amide derivatives; acts on cells expressing multidrug resistant phenotypes |
| 09/01/2009 | US7582632 Tri(cyclo) substituted amide compounds |
| 09/01/2009 | US7582631 Paget's disease; muscular disorders; cardiovascular disorders; antiinflamamtory agents; antidiabetic agents; autoimmune disease; leukemia |
| 09/01/2009 | US7582366 Difluoropyridine-based compound and organic electroluminescent device using the same |
| 09/01/2009 | CA2367368C Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands |
| 08/27/2009 | WO2009105509A1 Amine and ether compounds which modulate the cb2 receptor |
| 08/27/2009 | WO2009104990A1 2,4-diaminopyridine derivatives, a pharmaceutical composition and a medicinal agent which are based thereon and used for treating or preventing diseases and disturbances caused by the hyperactivation of nmda-receptors and/or in the form of cognitive function stimulators and a method for the use thereof |
| 08/27/2009 | WO2009104520A1 Method for producing phenoxypyridine derivative |
| 08/27/2009 | WO2009103950A1 Fluorinated pyridin-4-0nes |
| 08/27/2009 | WO2009103778A1 Compounds and methods |
| 08/27/2009 | WO2009103478A1 Pyridone and pyridazinone derivatives as mch antagonists |
| 08/27/2009 | WO2009026248A3 Hydrazide, amide, phthalimide and phthalhydrazide analogs as inhibitors of retroviral integrase |
| 08/27/2009 | WO2008154905A3 Modifications of the histone deacetylase inhibitor suberoylanilide hydroxamic acid |
| 08/27/2009 | WO2006087393A3 Structural analogues of avenanthramides, their use in compositions useful in the treatment of dermatological disorders |
| 08/27/2009 | US20090216024 Processes for making pioglitazone and compounds of the processes |
| 08/27/2009 | US20090216017 Process for producing biaryl compound |
| 08/27/2009 | US20090216015 Base Stable Ionic Liquids |
| 08/27/2009 | US20090216013 e.g.1,1-Dicyclohexyl-3-[5-(pyridin-2-ylsulfanyl)-thiazol-2-yl]-urea; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial, in particular, type 2 diabetes |
| 08/27/2009 | US20090215838 Organic nitric oxide enhancing salts of angiotensin ii antagonists, compositions and methods of use |
| 08/27/2009 | US20090215834 Heterocyclic inhibitors of mek and methods of use thereof |
| 08/27/2009 | US20090215833 Thermodynamically stable form of a tosylate salt |
| 08/27/2009 | US20090215800 Enzyme and Receptor Modulation |
| 08/27/2009 | US20090215795 Cyclic amidine derivatives |
| 08/27/2009 | US20090215780 Preparation and Use of Aryl Alkyl Acid Derivatives for the Treatment of Obesity |
| 08/27/2009 | US20090215705 Alpha 7 Nicotinic Receptor Selective Ligands |
| 08/27/2009 | US20090215623 Insecticidal 3-acylaminobenzanilides |
| 08/27/2009 | US20090214460 Composition Comprising a Monomer Compound Exhibiting an Optical Property, Method Making Use of Said Composition, a Monomer Compound and a Polymer Containing Said Monomer Compound and the Use Thereof |
| 08/27/2009 | DE202009007976U1 Neue Pharmazeutika und Arzneimittelzubereitungen, welche die Tumorzellproliferation und/oder Tumorvaskularisation hemmen, und ihre Wirkung als Multi-Kinase-Inhibitoren New pharmaceuticals and pharmaceutical compositions which inhibit tumor cell proliferation and / or tumor vascularization, and its effect as a multi-kinase inhibitors |
| 08/27/2009 | CA2716515A1 Amine and ether compounds which modulate the cb2 receptor |
| 08/26/2009 | EP2093216A1 Process for preparing substituted biphenylanilides |
| 08/26/2009 | EP2093214A1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 08/26/2009 | EP2091918A2 Compounds and compositions as protein kinase inhibitors |
| 08/26/2009 | EP2091917A1 Ion channel modulators |
| 08/26/2009 | EP1911746B1 The substance having antioxidant, geroprotective and anti-ischemic activity and method for preparing thereof |
| 08/26/2009 | EP1819693B1 Antithrombotic diamides |
| 08/26/2009 | EP1783116B1 2-phenylpyridine derivative |
| 08/26/2009 | EP1590338B1 Modulators of melanocortin receptor |
| 08/26/2009 | EP1298115B1 Process for the preparation of polyhydric alcohols |
| 08/26/2009 | CN101516850A Heteroaryl compounds useful as inhibitors of E1 activating enzymes |
| 08/26/2009 | CN101516849A 5-phenyl-nicotinamide derivatives |
| 08/26/2009 | CN101516848A N'-cyano-N-alkyl halide imide amide derivatives |
| 08/26/2009 | CN101516847A Process for the preparation of 2-substituted-5-(1-alkylthio)alkylpyridines |
| 08/26/2009 | CN101516846A Pyridine borane complexes |
| 08/26/2009 | CN101516839A Compounds which modulate the cb2 receptor |
| 08/26/2009 | CN101516834A Isoserine derivatives for use as coagulation factor ixa inhibitors |
| 08/26/2009 | CN101516832A Method for producing alkaline (meth)acrylamides |
| 08/26/2009 | CN101514186A Method of environmentally friendly catalyzing and oxidizing 2-haloperidid to synthesize N-oxidized-2-haloperidid |
| 08/26/2009 | CN101514185A Preparation of 2-chloro-3-pyridinamine |
| 08/26/2009 | CN101514184A Synthetic method for 5-bromine-2-methylpyridine |
| 08/26/2009 | CN101514183A Hg(2, 6-bis[1-(2,4,6-trimethylphenyl imine)ethyl]naphthyridine)Cl2and a preparation method |
| 08/26/2009 | CN101514182A Method for preparing beta, beta'-binary (4-pyridyl) divinylbenzene |
| 08/26/2009 | CN101514141A Synthetic method for allyl alcohol-like compound |
| 08/26/2009 | CN101513619A Tungsten-based catalyst used for oxidation reaction of pyridine and derivatives thereof and preparing method thereof |
| 08/26/2009 | CN100533145C Array compring structural unit and artificial receptors and its preparation method and structural unit |
| 08/26/2009 | CN100532365C Method of continuously synthesizing ionic liquid at room temperature |
| 08/26/2009 | CN100532361C 3-cyanopyridine absorption method |
| 08/26/2009 | CN100532360C Method for treating 4 chloro pyridine in solvent |
| 08/26/2009 | CN100532359C Method of synthesizing ion liquid at room temperature |
| 08/26/2009 | CN100531732C Thiomolybdate analogues |
| 08/25/2009 | US7579486 Metalloprotein inhibitors |
| 08/25/2009 | US7579475 reacting amlodipine with nicotinic acid in an organic solvent to form amlodipine nicotinate salt; and recrystallizing formed salt with a mixture of solvents containing methanol and isopropanol or water and isopropanol Photostability; enhanced pharmacological activity |
| 08/25/2009 | US7579469 For therapy of disease characterized by inflammatory, allergic, or proliferative processes |
| 08/25/2009 | US7579379 bis-[2-(pivaloylamino)phenyl]disulfide; cholesteryl ester transfer protein (CETP); atherosclerosis, hyperlipidemia |
| 08/25/2009 | US7579367 Aryl substituted pyridines and the use thereof |
| 08/25/2009 | US7579364 N-deacetylthiocolchicine derivatives, their use and pharmaceutical formulations containing them |
| 08/25/2009 | US7579352 Retinoic acid mimetic anilides |
| 08/25/2009 | US7579347 Vanilloid receptor ligands and their use in treatments |
| 08/25/2009 | CA2538072C Amide-type carboxamide derivatives |
| 08/25/2009 | CA2474578C Novel pyridin- and pyrimidin-derivatives |
| 08/25/2009 | CA2405172C Alpha,beta-unsaturated sulfones for treating proliferative disorders |
| 08/25/2009 | CA2375671C 4-phenyl-pyrimidine derivatives |
| 08/25/2009 | CA2366932C Cyclic protein tyrosine kinase inhibitors |
| 08/25/2009 | CA2326815C Process for preparation of pyridine derivatives |
| 08/20/2009 | WO2009101432A2 Process for preparing pyridone derivatives |
| 08/20/2009 | WO2009100827A1 Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and use thereof |
| 08/20/2009 | WO2009077068A9 Ester derivatives as phosphodiesterase inhibitors |
| 08/20/2009 | WO2009074749A3 Nicotinamide derivatives, preparation thereof and therapeutic use thereof |
| 08/20/2009 | US20090209767 2-(Butyl-1-sulfonylamino)-n-[1(R)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound |
| 08/20/2009 | US20090209762 Photosensitizer dye |
| 08/20/2009 | US20090209588 Novel compounds, their preparation and use |
| 08/20/2009 | US20090209586 Piperidine derivatives as human papilloma virus inhibitors |
| 08/20/2009 | US20090209542 mitogen activated protein kinase inhibitors; 4-(2-Fluoro-4-(methylthio)phenylamino)-N-(2-hydroxyethoxy)-1-methyl-6-oxo-1,6-dihydropyridazine-3-carboxamide; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals |
| 08/20/2009 | US20090206326 Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 08/20/2009 | DE102008008838A1 Cycloalkoxy-substituierte 4-Phenyl-3,5-dicyanopyridine und ihre Verwendung Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and their use |